Merck KGaA (OTCMKTS:MKGAF) Sees Significant Growth in Short Interest

Merck KGaA (OTCMKTS:MKGAF) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 555,200 shares, an increase of 27.9% from the February 13th total of 434,000 shares. Currently, 0.4% of the company’s stock are short sold. Based on an average trading volume of 600 shares, the days-to-cover ratio is currently 925.3 days.

Merck KGaA Stock Up 2.0 %

OTCMKTS MKGAF traded up $2.94 on Monday, hitting $149.15. 780 shares of the company were exchanged, compared to its average volume of 788. The company has a market cap of $19.28 billion, a PE ratio of 22.77 and a beta of 0.96. Merck KGaA has a 12 month low of $135.00 and a 12 month high of $200.56. The stock has a fifty day moving average of $146.49 and a 200-day moving average of $157.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.